Medicare Enrolled

Dr. Luis Rodriguez, M.D.

Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
155 E SONTERRA BLVD, San Antonio, TX 78258
2105935700
In practice since 2006 (19 years)
NPI: 1942234216 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodriguez

Dr. Luis Rodriguez is a medical oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez performed 12,671 Medicare services across 1,472 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rodriguez received a total of $19,744 from 68 pharmaceutical and/or device companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 39% volume in TX $19,744 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,671
Medicare services
Top 39% in TX for medical oncology
1,472
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~667 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 8,220 $18 $71
Dexamethasone injection (steroid) 970 $0 $0
Complete blood count (CBC) with differential 486 $8 $23
Blood draw (venipuncture) 420 $8 $15
Comprehensive metabolic blood panel 419 $10 $32
Office visit, established patient (30-39 min) 296 $89 $373
Office visit, established patient (20-29 min) 275 $63 $264
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 218 $21 $86
Administration of chemotherapy into vein, 1 hour or less 158 $95 $376
Drug injection, under skin or into muscle 127 $11 $47
Lactate dehydrogenase (enzyme) level 123 $6 $18
Administration of additional new drug or substance into vein, 1 hour or less 101 $46 $205
Injection of additional new drug or substance into vein 82 $11 $58
Complete blood count (CBC), automated 71 $6 $19
Ferritin level test (iron stores) 70 $13 $41
Iron level test 68 $6 $19
Iron binding capacity test 68 $9 $26
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 58 $329 $1,404
Administration of chemotherapy into vein, each additional hour 49 $22 $90
Carcinoembryonic antigen (cea) protein level 46 $19 $57
Office visit, established patient, complex (40-54 min) 46 $133 $523
Hospital follow-up visit, moderate complexity 45 $62 $232
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 39 $49 $184
Magnesium level test 37 $6 $20
Immunoglobulin level test 35 $9 $28
New patient office visit, complex (60-74 min) 35 $167 $641
Hospital follow-up visit, low complexity 24 $39 $145
Basic metabolic blood panel 22 $8 $25
New patient office visit (45-59 min) 22 $117 $486
Hospital follow-up visit, high complexity 21 $93 $349
Liver function blood test panel 20 $8 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
76.3% medium
21.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$19,744
Total received (2018-2024)
Avg $2,821/year across 7 years
Top 30% in TX for medical oncology
68
Companies
485
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,053 (91.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,401 (7.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$289 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,566
2023
$2,548
2022
$1,920
2021
$819
2020
$2,090
2019
$2,382
2018
$6,418

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,972
E.R. Squibb & Sons, L.L.C.
$2,914
AstraZeneca UK Limited
$2,359
Janssen Biotech, Inc.
$1,181
Genentech USA, Inc.
$873
Novartis Pharmaceuticals Corporation
$665
Amgen Inc.
$606
Regeneron Healthcare Solutions, Inc.
$595
Adaptive Biotechnologies Corporation
$543
Lilly USA, LLC
$451
PFIZER INC.
$437
Karyopharm Therapeutics Inc.
$364
GlaxoSmithKline, LLC.
$319
Daiichi Sankyo Inc.
$319
Eisai Inc.
$318
Takeda Pharmaceuticals U.S.A., Inc.
$302
Gilead Sciences, Inc.
$289
Kite Pharma, Inc.
$274
Puma Biotechnology, Inc.
$267
BeiGene USA, Inc.
$250
GENZYME CORPORATION
$241
Tempus AI, Inc
$236
Exelixis Inc.
$218
Merck Sharp & Dohme LLC
$215
Seagen Inc.
$181
Ipsen Biopharmaceuticals, Inc
$172
AbbVie, Inc.
$159
Coherus Biosciences Inc.
$147
Incyte Corporation
$146
LivaNova USA, Inc.
$135
PharmaEssentia USA Corporation
$109
ADC Therapeutics America, Inc.
$95
Astellas Pharma US Inc
$91
Celgene Corporation
$90
AVEO Pharmaceuticals, Inc.
$83
Taiho Oncology, Inc.
$80
Merck Sharp & Dohme Corporation
$79
SERVIER PHARMACEUTICALS LLC
$70
SOBI, INC
$63
Bayer Healthcare Pharmaceuticals Inc.
$59
Mirati Therapeutics, Inc.
$54
Pharmacyclics LLC, An AbbVie Company
$46
TAIHO ONCOLOGY, INC.
$45
EISAI INC.
$42
PUMA BIOTECHNOLOGY, INC.
$40
Genmab U.S., Inc.
$39
MorphoSys, US Inc.
$38
Janssen Pharmaceuticals, Inc
$36
EMD Serono, Inc.
$35
Kyowa Kirin, Inc.
$35
AbbVie Inc.
$34
Medtronic USA, Inc.
$28
Helsinn Therapeutics (U.S.), Inc.
$27
SANOFI PASTEUR INC.
$26
Seattle Genetics, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
ABBVIE INC.
$23
Rigel Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Blueprint Medicines Corporation
$19
CTI BioPharma Corp.
$18
Acrotech Biopharma Inc.
$16
Sanofi Pasteur Inc.
$16
Geron Corporation
$15
Amneal Pharmaceuticals LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 41.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MENACTRA · MENQUADFI · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · PADCEV · PIQRAY · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Perjeta · Pomalyst · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNCHROMED · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VNS Therapy · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Yescarta · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $156 per 100 Medicare services performed
Looking for a medical oncology specialist in San Antonio?
Compare medical oncologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
38
Per 100K population
1.9
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rodriguez is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rodriguez experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rodriguez performed 8,220 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $19,744 from 68 companies across 485 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other medical oncologists in San Antonio?
Dr. Rodriguez's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →